StockClub

BTAI

BTAIBioXcel Therapeutics, Inc.$ --
BioXcel Therapeutics, Inc.

BioXcel Therapeutics, Inc.

BTAI

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
0M USD
YoY +22.6%
Operating Income
-10M USD
YoY -0.2%
Net Income
-13M USD
YoY -75.0%
EPS
-1.04$
YoY +30.7%

Revenue

$206,000
FY2024 Q2$1.7M
$1.7M
Q2
FY2024 Q3$1.9M
$1.9M
Q3
FY2024 Q4$2.3M
$2.3M
Q4
FY2025 Q1$168,000
$168,000
Q1
FY2025 Q2$288,000
$288,000
Q2
FY2025 Q3$386,000
$386,000
Q3
FY2025 Q4$642,000
$642,000
Q4
FY2026 Q1$206,000
$206,000
Q1
Actual
+$38,000 (+22.6%)

Net Income

$-12.7M
FY2024 Q2$-35.1M
$-35.1M
Q2
FY2024 Q3$-48.7M
$-48.7M
Q3
FY2024 Q4$-59.6M
$-59.6M
Q4
FY2025 Q1$-7.3M
$-7.3M
Q1
FY2025 Q2$-26.4M
$-26.4M
Q2
FY2025 Q3$-57.4M
$-57.4M
Q3
FY2025 Q4$-69.9M
$-69.9M
Q4
FY2026 Q1$-12.7M
$-12.7M
Q1
Actual
$-5.4M (-75.0%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$0
FY2020
$0
FY2021
Actual:$0
FY2021
$0
FY2022MISS
Actual:$375,000
Est:$1.2M
FY2022MISS
$375,000
FY2023MISS
Actual:$1.4M
Est:$2.4M
FY2023MISS
$1.4M
FY2024BEAT
Actual:$2.3M
Est:$2.2M
FY2024BEAT
$2.3M
FY2025BEAT
Actual:$642,000
Est:$559,360
FY2025BEAT
$642,000

Analyst Estimates